Connectome‐Based Propagation Model in Amyotrophic Lateral Sclerosis

OBJECTIVE: Clinical trials in amyotrophic lateral sclerosis (ALS) continue to rely on survival or functional scales as endpoints, despite the emergence of quantitative biomarkers. Neuroimaging‐based biomarkers in ALS have been shown to detect ALS‐associated pathology in vivo, although anatomical pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Meier, Jil M., van der Burgh, Hannelore K., Nitert, Abram D., Bede, Peter, de Lange, Siemon C., Hardiman, Orla, van den Berg, Leonard H., van den Heuvel, Martijn P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186838/
https://www.ncbi.nlm.nih.gov/pubmed/32072667
http://dx.doi.org/10.1002/ana.25706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7186838/
https://www.ncbi.nlm.nih.gov/pubmed/32072667
http://dx.doi.org/10.1002/ana.25706

Ejemplares similares